This study is in progress, not accepting new patients
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine
- Dates
- study startestimated completion
- Principal Investigator
- by Angela G. Fleischman (uci)
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Angela G. Fleischman (uci)
Associate Professor, Medicine, School of Medicine. Authored (or co-authored) 44 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, Irvine
- ID
- NCT05123365
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 27 study participants
- Last Updated